Published in Virchows Arch on December 29, 2011
The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: data from individual patients and family studies. Mol Genet Metab (2014) 0.90
Variations in the GLA gene correlate with globotriaosylceramide and globotriaosylsphingosine analog levels in urine and plasma. Clin Chim Acta (2015) 0.77
Characterization and phosphoproteomic analysis of a human immortalized podocyte model of Fabry disease generated using CRISPR/Cas9 technology. Am J Physiol Renal Physiol (2016) 0.76
Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease. PLoS One (2016) 0.75
Fabry's disease. Lancet (2008) 2.89
Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab (2007) 2.51
FABRY'S DISEASE: CLASSIFICATION AS A SPHINGOLIPIDOSIS AND PARTIAL CHARACTERIZATION OF A NOVEL GLYCOLIPID. J Biol Chem (1963) 2.24
The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases. JAMA (2006) 2.21
Cellular and tissue localization of globotriaosylceramide in Fabry disease. Virchows Arch (2007) 1.91
Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells. Kidney Int (2000) 1.77
Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int (1998) 1.70
Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int (1978) 1.56
Renal pathology in Fabry disease. J Am Soc Nephrol (2002) 1.34
Roles of globotriosyl- and galabiosylceramide in verotoxin binding and high affinity interferon receptor. J Biol Chem (1987) 1.34
X-inactivation patch size in human female tissue confounds the assessment of tumor clonality. Proc Natl Acad Sci U S A (2003) 1.30
Light- and electron-microscopic histochemistry of Fabry's disease. Am J Pathol (1981) 1.17
Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrol Dial Transplant (2009) 1.15
Verotoxins induce apoptosis in human renal tubular epithelium derived cells. Kidney Int (1998) 1.02
Fabry disease: a morphologic study of 11 cases. Mod Pathol (2006) 1.01
Generation of one set of murine monoclonal antibodies specific for globo-series glycolipids: evidence for differential distribution of the glycolipids in rat small intestine. Arch Biochem Biophys (1994) 0.97
Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy. Virchows Arch (2008) 0.91
A female heterozygous patient with Fabry's disease with renal accumulation of trihexosylceramide detected with a monoclonal antibody. Am J Kidney Dis (1995) 0.89
Shigatoxin-1 binding and receptor expression in human kidneys do not change with age. Pediatr Nephrol (2003) 0.88
Renal ultrastructural findings in Anderson-Fabry disease. J Nephrol (2002) 0.85
Splenomegaly, hypersplenism and peripheral blood cytopaenias in patients with classical Anderson-Fabry disease. Virchows Arch (2008) 0.82
The renal lesion in angiokeratoma corporis diffusum (Fabry's disease). Can Med Assoc J (1963) 0.79
Renal involvement in Anderson-Fabry disease. J Nephrol (2003) 0.78
Immunoelectron-microscopic detection of globotriaosylceramide accumulated in the skin of patients with Fabry disease. Br J Dermatol (2005) 0.78
Cellular and tissue localization of globotriaosylceramide in Fabry disease. Virchows Arch (2008) 0.75
Clinical, histopathological, and biochemical findings in Fabry's disease. A case report and family study. Arch Pathol Lab Med (1977) 0.75
Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst (2002) 4.43
Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer (2006) 2.89
The prevalence of PIK3CA mutations in gastric and colon cancer. Eur J Cancer (2005) 2.83
Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet Metab (2007) 2.51
A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology (2003) 2.39
Breast cancer stem cell markers CD44, CD24 and ALDH1: expression distribution within intrinsic molecular subtype. J Clin Pathol (2011) 2.33
Epithelial E- and P-cadherins: role and clinical significance in cancer. Biochim Biophys Acta (2012) 1.64
Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 1.55
Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study. Carcinogenesis (2006) 1.43
Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet (2003) 1.42
BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis? BMC Cancer (2008) 1.30
Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol (2006) 1.29
Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Am J Clin Nutr (2009) 1.28
The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev (2007) 1.23
End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry. Nephrol Dial Transplant (2009) 1.22
Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology (2009) 1.21
Fruit and vegetable consumption and gastric cancer by location and histological type: case-control and meta-analysis. Eur J Cancer Prev (2007) 1.21
Mutations of the GLA gene in young patients with stroke: the PORTYSTROKE study--screening genetic conditions in Portuguese young stroke patients. Stroke (2010) 1.19
E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients. Eur J Cancer (2004) 1.17
Biomarkers for gastric cancer: prognostic, predictive or targets of therapy? Virchows Arch (2014) 1.15
Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN). Nephrol Dial Transplant (2009) 1.15
Oncogenic mutations in gastric cancer with microsatellite instability. Eur J Cancer (2011) 1.14
Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clin Cancer Res (2009) 1.14
Hereditary gastric cancer. Best Pract Res Clin Gastroenterol (2009) 1.12
De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Lab Invest (2010) 1.10
The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Hum Mol Genet (2009) 1.09
Smoking, Helicobacter pylori virulence, and type of intestinal metaplasia in Portuguese males. Cancer Epidemiol Biomarkers Prev (2007) 1.08
Epidermal growth factor receptor structural alterations in gastric cancer. BMC Cancer (2008) 1.07
How well does urinary lyso-Gb3 function as a biomarker in Fabry disease? Clin Chim Acta (2010) 1.06
Diagnosis of gastric syphilis by direct immunofluorescence staining and real-time PCR testing. J Clin Microbiol (2006) 1.06
Loss of heterozygosity and promoter methylation, but not mutation, may underlie loss of TFF1 in gastric carcinoma. Lab Invest (2002) 1.05
E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells. Hum Mol Genet (2003) 1.02
E-cadherin and adherens-junctions stability in gastric carcinoma: functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases III and V. Biochim Biophys Acta (2013) 1.01
Evaluation of clinico-pathological features and Helicobacter pylori infection in gastric inflammatory fibroid polyps. Virchows Arch (2014) 0.98
Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch (2001) 0.98
The interleukin-8-251*T/*A polymorphism is not associated with risk for gastric carcinoma development in a Portuguese population. Eur J Cancer Prev (2008) 0.98
E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions. FEBS Lett (2012) 0.98
Intragenic deletion of CDH1 as the inactivating mechanism of the wild-type allele in an HDGC tumour. Oncogene (2004) 0.97
Colorectal cancer and RASSF family--a special emphasis on RASSF1A. Int J Cancer (2012) 0.96
Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations. Nephrol Dial Transplant (2009) 0.96
Gastric cancer: adding glycosylation to the equation. Trends Mol Med (2013) 0.96
c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma. Int J Surg Pathol (2002) 0.95
Evaluation of HER2 in breast cancer: reality and expectations. Expert Opin Med Diagn (2009) 0.95
MSI phenotype and MMR alterations in familial and sporadic gastric cancer. Int J Cancer (2010) 0.94
Prospective study of physical activity and risk of primary adenocarcinomas of the oesophagus and stomach in the EPIC (European Prospective Investigation into Cancer and nutrition) cohort. Cancer Causes Control (2010) 0.93
Patterns of beta-catenin expression in gastric carcinoma: clinicopathological relevance and mutation analysis. Int J Surg Pathol (2003) 0.93
Role of pathology in the identification of hereditary diffuse gastric cancer: report of a Portuguese family. Virchows Arch (2004) 0.92
Tumor necrosis factor alpha extended haplotypes and risk of gastric carcinoma. Cancer Epidemiol Biomarkers Prev (2008) 0.92
DNA copy number profiles of gastric cancer precursor lesions. BMC Genomics (2007) 0.91
Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy. Virchows Arch (2008) 0.91
Genetic changes of CEBPA in cancer: mutations or polymorphisms? J Clin Oncol (2007) 0.90
Helicobacter pylori colonization of the adenotonsillar tissue: fact or fiction? Int J Pediatr Otorhinolaryngol (2010) 0.89
DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int J Epidemiol (2008) 0.88
Antioxidant vitamins and risk of gastric cancer: a case-control study in Portugal. Nutr Cancer (2006) 0.88
NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn's disease. Inflamm Bowel Dis (2005) 0.88
Loss of functional E-cadherin renders cells more resistant to the apoptotic agent taxol in vitro. Exp Cell Res (2005) 0.88
Vitamins B2 and B6 and genetic polymorphisms related to one-carbon metabolism as risk factors for gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev (2010) 0.88
Juvenile polyps have gastric differentiation with MUC5AC expression and downregulation of CDX2 and SMAD4. Histochem Cell Biol (2009) 0.87
Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components. Cell Oncol (2006) 0.87
E-cadherin alterations in hereditary disorders with emphasis on hereditary diffuse gastric cancer. Prog Mol Biol Transl Sci (2013) 0.87
E-cadherin impairment increases cell survival through Notch-dependent upregulation of Bcl-2. Hum Mol Genet (2011) 0.87
C/EBP alpha expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis. Lab Invest (2010) 0.87
Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours. Hum Mol Genet (2009) 0.86
Deletion of the 5'exons of COL4A6 is not needed for the development of diffuse leiomyomatosis in patients with Alport syndrome. J Med Genet (2013) 0.86
Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens. J Clin Microbiol (2013) 0.86
Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas. J Pathol (2003) 0.86
CDH1 gene polymorphisms, smoking, Helicobacter pylori infection and the risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Eur J Cancer (2008) 0.85
Aberrant P-cadherin expression: is it associated with estrogen-independent growth in breast cancer? Pathol Res Pract (2002) 0.85
Angiokeratomas of Fabry successfully treated with intense pulsed light. J Cosmet Laser Ther (2008) 0.84
Genetic screening for familial gastric cancer. Hered Cancer Clin Pract (2004) 0.83
Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome. BMC Cancer (2014) 0.83
Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2. Diagn Cytopathol (2003) 0.82
First degree relatives and familial aggregation of gastric cancer: who to choose for control in case-control studies? Fam Cancer (2012) 0.81
Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2. Histopathology (2014) 0.80
Impact of peginterferon alpha-2b and ribavirin treatment on liver tissue in patients with HCV or HCV-HIV co-infection. J Infect (2006) 0.80
Dialysis and transplantation in Fabry disease: indications for enzyme replacement therapy. Clin J Am Soc Nephrol (2010) 0.80
Clinical utility gene card for: Hereditary diffuse gastric cancer (HDGC). Eur J Hum Genet (2013) 0.79
Kidney histologic alterations in α-Galactosidase-deficient mice. Virchows Arch (2011) 0.79
Functional transcranial Doppler: presymptomatic changes in Fabry disease. Eur Neurol (2012) 0.79
Who takes the lead in the development of ulcerative colitis-associated colorectal cancers: mutator, suppressor, or methylator pathway? Cancer Genet Cytogenet (2005) 0.78
First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile. Virchows Arch (2013) 0.77
The Modulatory Effects of the Polymorphisms in GLA 5'-Untranslated Region Upon Gene Expression Are Cell-Type Specific. JIMD Rep (2015) 0.77
PNA-FISH as a new diagnostic method for the determination of clarithromycin resistance of Helicobacter pylori. BMC Microbiol (2011) 0.77
Genetic variants in the IL1A gene region contribute to intestinal-type gastric carcinoma susceptibility in European populations. Int J Cancer (2014) 0.77
Cereal fiber intake may reduce risk of gastric adenocarcinomas: the EPIC-EURGAST study. Int J Cancer (2007) 0.77
Association between environmental factors and CDX2 expression in gastric cancer patients. Eur J Cancer Prev (2012) 0.77
AIRP best cases in radiologic-pathologic correlation: gastroblastoma: a rare biphasic gastric tumor. Radiographics (2014) 0.77
History, pathogenesis, and management of familial gastric cancer: original study of John XXIII's family. Biomed Res Int (2012) 0.76
Temporal intradiploic dilative vasculopathy: an additional pathogenic factor for the hearing loss in fabry disease? JIMD Rep (2012) 0.75
GRIM-19 mutations are not associated with Crohn's disease. Inflamm Bowel Dis (2008) 0.75
Familial occurrence of nodular regenerative hyperplasia of the liver. Am J Gastroenterol (2013) 0.75
Immunophenotype of sporadic and familial adenomatous polyposis associated fundic gland polyps: a mucin and MIB1 study. Pol J Pathol (2006) 0.75
Phenotypic expression in the first case of complete trisomy 12: combination of prenatal ultrasound and necropsic examination. Fetal Diagn Ther (2009) 0.75
Establishment of a Tumour Bank: the experience of the Department of Pathology of Hospital S. João (Porto, Portugal). Cell Tissue Bank (2008) 0.75
Phlegmonous gastritis: a rare cause of abdominal pain. J Pediatr Gastroenterol Nutr (2015) 0.75
Novel human pathological mutations. Gene symbol: NOTCH3. Disease: cerebral autosomal dominant aretriopathy with subcortical infarcts and leukoencephalopathy. Hum Genet (2007) 0.75
Novel human pathological mutations. Gene symbol: GLA. Disease: Fabry disease. Hum Genet (2009) 0.75
Novel human pathological mutations. Gene symbol: NOTCH3. Disease: cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL). Hum Genet (2007) 0.75